ArticleInternational journal of women's health2026
Analyzing the Risk Factors for Recurrence of Endometrioma and Dysmenorrhea in Patients with Endometriosis.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recurrence of endometrioma and dysmenorrhea after surgery remains a major clinical challenge. Identifying reliable risk factors is essential to optimize individualized treatment and follow-up strategies. However, large-scale data from Chinese populations are limited. Materials and Methods: We retrospectively analyzed 1,598 reproductive-aged women with pathologically confirmed endometriosis who underwent surgery between 2009 and 2010 and were followed for up to 7 years. Clinical, surgical, and follow-up data were collected. Kaplan-Meier survival analysis and Cox proportional hazards models were used to assess recurrence and identify independent predictors. Results: During follow-up, 348 patients (21.8%) developed endometrioma recurrence, and 187 of 846 with baseline dysmenorrhea (22.1%) experienced recurrence. The cumulative recurrence rates were 12%, 38%, 55%, and 65% for endometrioma at 1, 3, 5, and 7 years, and 28%, 52%, 68%, and 75% for dysmenorrhea at 1, 3, 5, and 7 years. Multivariable Cox regression identified bilateral ovarian cysts (HR 1.36, 95% CI 1.06-1.74, P = 0.015), older age at surgery (HR 1.04, 95% CI 1.00-1.08, P = 0.029), lack of postoperative medical therapy (HR 2.10, 95% CI 1.28-3.46, P = 0.003), and higher postoperative VAS scores (HR 1.10, 95% CI 1.05-1.15, P < 0.001) as independent risk factors for endometrioma recurrence. For dysmenorrhea recurrence, significant predictors were a history of endometriosis (HR 2.06, 95% CI 1.19-3.57, P = 0.010), higher preoperative VAS scores (HR 1.14, 95% CI 1.02-1.28, P = 0.026), and higher postoperative VAS scores (HR 1.27, 95% CI 1.18-1.39, P < 0.001). Conclusion: Recurrence of endometrioma and dysmenorrhea is common after surgery. Bilateral cysts, older age, lack of postoperative therapy, and higher postoperative pain scores independently increase the risk of endometrioma recurrence, while both preoperative and postoperative pain severity, as well as a history of endometriosis, are strong predictors of dysmenorrhea recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.